🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial is studying the safety and efficacy of a personalized c...
Status
Recruiting
Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Start Date
2024-03-01
Trial ID
NCT07002203
Treatments Being Tested
This clinical trial aims to evaluate the safety, immunogenicity, and prelim...
Status
Completed
Location
Vejthani Hospital
Start Date
2022-11-24
Trial ID
NCT06614140
Treatments Being Tested
The main purpose of this study is to determine the dose of poly-ICLC that i...
Status
Completed
Location
Georgia Cancer Center at Augusta University
Start Date
2018-01-10
Trial ID
NCT02834052
Treatments Being Tested
The primary objective of this study is to assess the safety and tolerabilit...
Status
Unknown
Location
Shanghai 10th People's Hospital
Start Date
2022-09-13
Trial ID
NCT05557240
Treatments Being Tested
This is a phase 1b study of P30-linked EphA2, CMV pp65, and survivin vaccin...
Status
Active Not Recruiting
Location
The Preston Robert Tisch Brain Tumor Center at Duke University
Start Date
2023-08-30
Trial ID
NCT05283109
Treatments Being Tested
This phase I trial evaluates the safety and effectiveness of in situ immuno...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2023-01-09
Trial ID
NCT04616248
The purpose of this research study is to evaluate Immunotherapy with a pept...
Status
Active Not Recruiting
Location
Lee Moffitt Cancer Center and Research Institute
Start Date
2016-08-18
Trial ID
NCT02826434
Treatments Being Tested
This is a Phase Ib study to look at the combination of an antibody immuniza...
Status
Terminated
Location
Florida Hospital Cancer Institute
Start Date
2017-05-30
Trial ID
NCT03162562
Treatments Being Tested
This is a phase II study to determine the immunogenicity and efficacy of a ...
Status
Withdrawn
Location
NYU Perlmutter Cancer Center
Start Date
2016-11
Trial ID
NCT02754362
Treatments Being Tested
The major purpose of this study is to examine the anti-tumor activity of th...
Status
Terminated
Location
BCG Oncology, PC
Start Date
2010-04
Trial ID
NCT01094496
Treatments Being Tested